Model
Edge
Seres Therapeutics
0001767321
Filing Type
4
Filing Date
11/17/2025
Updated
11/18/25, 2:30 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership